首页 | 本学科首页   官方微博 | 高级检索  
检索        

银杏叶提取物注射液联合神经节苷脂治疗缺血性脑血管病的疗效观察
引用本文:邹蓉,刘朝霞,曲晓宁,刘玺昌.银杏叶提取物注射液联合神经节苷脂治疗缺血性脑血管病的疗效观察[J].现代药物与临床,2015,30(7):850-853.
作者姓名:邹蓉  刘朝霞  曲晓宁  刘玺昌
作者单位:滨州医学院烟台附属医院神经内科,山东烟台,264100
摘    要:目的探索银杏叶提取物注射液联合神经节苷脂治疗缺血性脑血管病的临床疗效。方法选取2013年9月—2014年12月滨州医学院烟台附属医院收治的缺血性脑血管病患者98例,随机分为对照组和治疗组,每组各49例。对照组患者静脉滴注单唾液酸四己糖神经节苷脂钠注射液,60 mg加入250 m L生理盐水中,1次/d。治疗组在对照组基础上静脉滴注银杏叶提取物注射液,20 m L加入500 m L生理盐水中,1次/d。两组患者均连续治疗14 d。治疗后,观察两组的临床疗效,同时比较两组患者血液流变学指标、NIHSS评分和Barthel指数的变化。结果治疗后,对照组和治疗组的总有效率分别为75.51%、89.80%,两组总有效率比较差异有统计学意义(P0.05)。治疗后,两组患者全血黏度、血浆黏度、纤维蛋白原、红细胞压积、NIHSS评分均较治疗前显著降低,Barthel指数升高,同组治疗前后差异有统计学意义(P0.05),治疗后,治疗组这些血液流变学指标的改善程度优于对照组,两组比较差异具有统计学意义(P0.05)。结论银杏叶提取物注射液联合神经节苷脂治疗缺血性脑血管病疗效显著,可促进神经功能修复,提高患者生活质量,具有一定的临床推广应用价值。

关 键 词:银杏叶提取物注射液  单唾液酸四己糖神经节苷脂钠注射液  缺血性脑血管病
收稿时间:3/2/2015 12:00:00 AM

Clinical observation of Extract of Ginkgo biloba Leaves Injection combined with ganglioside in treatment of ischemic cerebrovascular disease
ZOU Rong,LIU Zhao-xi,QU Xiao-ning and LIU Xi-chang.Clinical observation of Extract of Ginkgo biloba Leaves Injection combined with ganglioside in treatment of ischemic cerebrovascular disease[J].Drugs & Clinic,2015,30(7):850-853.
Authors:ZOU Rong  LIU Zhao-xi  QU Xiao-ning and LIU Xi-chang
Institution:Department of Neurology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai 264100, China;Department of Neurology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai 264100, China;Department of Neurology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai 264100, China;Department of Neurology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai 264100, China
Abstract:Objective To explore the clinical effect of Extract of Ginkgo biloba Leaves Injection combined with ganglioside in treatment of ischemic cerebrovascular disease. Methods Patients (98 cases) with ischemic cerebrovascular disease in Yantai Affiliated Hospital of Binzhou Medical University from September 2013 to December 2014 were randomly divided into control and treatment groups. Each group had 49 cases. Patients in control group were iv administered with Sodium Monosialotetrahexosylganglioside Injection (60 mg added in 250 mL physiological saline), once daily. Patients in treatment group were iv administered with Extract of Ginkgo biloba Leaves Injection on the basis of the control group (20 mL added in 500 mL physiological saline), once daily. Patients in two groups were treated for 14 d. After treatment, the efficacy was evaluated, the changes of blood rheology indexes, NIHSS score and Barthel index in two groups were compared. Results After the treatment, the efficacies in the control and treatment groups were 75.51% and 89.80%, respectively, and there were differences between two groups (P < 0.05). After treatment, the whole blood viscosity, plasma viscosity, fibrinogen, erythrocyte deposited, and NIHSS score in two groups were significantly reduced, and Barthel index was elevated, and the difference was statistically significant in the same group (P < 0.05). And these indicators in the treatment group improved better than those in the control group, with significant difference between two groups (P < 0.05). Conclusion Extract of Ginkgo biloba Leaves Injection combined with ganglioside has curative effect in treatment of ischemic cerebrovascular disease, and can promote restoration of the nerve function, also can improve patients life quality, which has a certain clinical application value.
Keywords:Extract of Ginkgo biloba Leaves Injection  Sodium Monosialotetrahexosylganglioside Injection  ischemic cerebrovascular disease
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《现代药物与临床》浏览原始摘要信息
点击此处可从《现代药物与临床》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号